Due tonational shortageof the nebulization solutions, theformulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products willautomatically return to their original formulary status. SeeAlbuterol/Duoneb Shortage Mitigationfor more information. (UpdatedFeb 2023)
Due to national shortage of the nebulization solutions, the formulary status of inhaler products has been temporarily adjusted to formulary, restricted to use during the albuterol/Duoneb shortage. Upon shortage resolution, these products will automatically return to their original formulary status. See Albuterol/Duoneb Shortage Mitigation for more information. (Updated Feb 2023)
ORDER FORMULATION
THERAPEUTIC INTERCHANGE
umeclidinium-vilantero (Anoro Ellipta)
albuterol-ipratropium (DuoNeb)
Anoro Ellipta medication guide
Anoro Ellipta is classified as non-formulary. Interchange Anoro Ellipta once daily to DuoNeb four times daily.
Reviewed: August 26, 2014 (Anoro Ellipta)